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Abstract: 
 
Six fungal metabolites, of which five were new, including one (1) with a dioxa[4.3.3]propellane 
ring system, were discovered, identified, and structurally elucidated from Neosetophoma sp. 
(strain MSX50044); these compounds are similar to the bis-tropolone, eupenifeldin. Three of the 
meroterpenoids are potent cytotoxic agents against breast, ovarian, mesothelioma, and lung 
cancer cells with nanomolar IC50 values while not inducing mitochondrial toxicity at 12.5 μM. 
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ABSTRACT: Six fungal metabolites, of which five were new, including one (1) with a dioxa[4.3.3]propellane ring system, were
discovered, identified, and structurally elucidated from Neosetophoma sp. (strain MSX50044); these compounds are similar to
the bis-tropolone, eupenifeldin. Three of the meroterpenoids are potent cytotoxic agents against breast, ovarian, mesothelioma,
and lung cancer cells with nanomolar IC50 values while not inducing mitochondrial toxicity at 12.5 μM.
Meroterpenoids, compounds originating from hybridterpenoid and polyketide biosynthesis, are significant
due to their wide-range of biological activities, the unusual
enzyme reactions that afford the connectivity of their
structures, and their unique ring systems.1,2 Neosetophoma
(Phaeosphaeriaceae) is a recently described ascomycete genus
in the kingdom fungi, and a very limited set of secondary
metabolites have been reported from Neosetophoma samaro-
rum.3 Herein, we report five new and one known
meroterpenoids (1−6; Figure 1), including the discovery of
a novel dioxa[4.3.3]propellane metabolite (1) that incorpo-
rates a 3-methyl-2,3-dihydrofuran bridge into a 5,6 tricyclic 2-
hydroxycyclopent-2-en-1-one/tetrahydropyran ring system,
from an undescribed Neosetophoma sp. [strain MSX50044;
see the Supporting Information (SI)], supporting the
hypothesis that new fungal species biosynthesize novel
chemical scaffolds.4 Specifically, we describe the isolation and
structural elucidation of the meroterpenoids, mitochondrial-
based toxicity, and cytotoxicity against breast, ovarian,
mesothelioma, and lung cancer cells.
Solid-phase cultures of Neosetophoma sp. were grown on rice
(see the SI). The organic extract [CHCl3−MeOH (1:1)] of
the fermentation culture exhibited potent cytotoxic activity
against H460 (lung) cancer cells when tested at 2 μg/mL.
After dereplication studies,5 the extract was purified using
normal-phase flash chromatography to afford eight fractions.
Fractions six and seven showed potent activities against H460
cells with 79% and 97% cell growth inhibition, respectively,
when tested at 2 μg/mL, and were subsequently chromato-
graphed on a C18 preparative HPLC column to yield
compounds neosetophomone A (1, 3.94 mg), neosetopho-
mone B (2, 56.38 mg), eupenifeldin (3, 296.95 mg),
dehydroxyeupenifeldin (4, 6.54 mg), noreupenifeldin B (5,
10.75 mg), and 22-hydroxyramiferin (6, 4.96 mg) (Figure 1
and Figure S1). The purity of 1−6 was >97% as assessed by
UPLC (Figure S2).
HRESIMS and 1D/2D NMR data identified compound 3 as
the bis-tropolone sesquiterpenoid, eupenifeldin6 (Table S1 and
Figures S3−S8). The absolute configuration of 3 was
confirmed as 8R,9S,10S,12S,13S by vibrational circular
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dichroism (VCD) (Figure S9), supportive of a recent report by
electronic circular dichroism (ECD).7
Compound 1 (3.94 mg) was isolated as a white amorphous
powder. The molecular formula was deduced as C24H32O5 by
HRESIMS, indicating an index of hydrogen deficiency of 9
(Figure S3). Comparison of the 1H, 13C, and edited-HSQC
NMR data of 1 with that of 3 suggested several intriguing
structural differences (Figures S10 and S11). In particular, it
appeared that 1 had only one dihydro-2H-pyran ring and
lacked both tropolone rings, as evidenced by the absence of the
characteristic tropolonic carbonyl resonances (i.e., ∼δC 172,
Table S1); it also lacked the aromatic methine singlets and the
aromatic carbons (Table 1 and Figures S10 and S11). The
COSY NMR spectrum of 1 displayed three isolated proton
spin systems (H-2/H2-3/H-4/H2-12, H2-6/H-7/H-8, and H2-
10/H-11), which were connected via tertiary and quaternary
carbons (C-5 and C-9, respectively), and one nonprotonated
vinylic carbon (C-1), constituting the 11-membered sesqui-
terpene ring (humulene unit C), which was fused with the
dihydro-2H-pyran at C-4/C-5 (Figures 2 and S12). HMBC
correlations from H-2 to C-4 and C-11, from H2-3 to C-1, C-5,
and C-12, from H2-6 to C-4, C-5, C-8, and C-23, from H2-10
to C-1 and C-8, and from H2-12 to C-3, C-4, and C-5
supported this connectivity (Table 1 and Figures 2 and S13).
The olefinic protons of the Δ7,8 double bond were in the E-
configuration (JH‑7/H‑8 = 13.2 Hz) (Table 1 and Figure S10). A
NOSEY correlation was observed between H-11 and H3-20,
confirming the E-configuration of the Δ1,11 double bond
(Figure S14). In comparison with 3, these data (a) established
the absence of the dihydro-2H-pyran-tropolone moieties (i.e.,
units A and B) in 1 and (b) accounted for four degrees of
unsaturation, specifically for the humulene ring, two double
bonds, and one dihydropyran. We were left to account for five
degrees of unsaturation using a methyl, a quaternary carbon, an
oxygenated tertiary carbon, a nonprotonated olefinic carbon,
two protonated olefinic carbons, an oxygenated olefinic carbon,
and an α,β-unsaturated ketone (δC 199.3). These data, along
with the fact that there were neither tropolone nor benzene
moieties in the structure of 1, indicated the existence of two
fused rings, which were established by extensive analysis of the
HMBC data as 2-hydroxycyclopent-2-en-1-one and 4-methyl-
Figure 1. Meroterpenoids (1−6) isolated from a Neosetophoma sp.
Table 1. 1H (500 MHz), 13C (125 MHz), and HMBC NMR
Data for 1 in CDCl3
position δC, type δH (J, Hz) HMBC (H→C)
1 137.1, C
2 68.5, CH 4.59 (dd, 8.0, 4.6) 20, 4, 11
3 38.5, CH2 1.42 (ddd, 14.9, 8.0, 5.2) 12, 4, 2, 5, 1
1.94 (ddd, 14.9, 6.3, 4.6) 12, 4, 2, 5, 1
4 31.5, CH 1.63 (m) 12
5 81.4, C
6 49.1, CH2 2.38 (dd, 12.6, 4.0) 23, 4, 5, 7, 8
2.49 (dd, 12.6, 8.0) 23, 4, 5, 7, 8
7 121.8, CH 5.26 (dd, 13.2, 4.0) 9
8 144.2, CH 5.26 (d, 13.2) 22, 6, 7
9 36.3, C
10 42.1, CH2 1.76 (dd, 13.2, 5.7) 22, 9, 11, 1, 8
2.11 (dd, 13.2, 12.0) 22, 9, 11, 1
11 125.7, CH 5.45 (dd, 12.0, 5.7) 20, 2
12 27.8, CH2 1.26 (dd, 13.8, 13.2) 4, 3, 13, 5, 18, 17
2.12 (dd, 13.8, 3.4) 3, 13, 5, 14
13 56.6, C
14 111.0, C
15 123.1, CH 6.28 (s) 13, 17
16 153.2, C
17 199.3, C
18 109.9, C
19 140.3, CH 6.14 (br. q, 1.7) 24, 13, 14
20 19.4, CH3 1.72 (s) 2, 11, 1
21 28.4, CH3 1.08 (s) 22, 9, 10, 8
22 26.8, CH3 1.04 (s) 21, 9, 10, 8
23 23.2, CH3 1.17 (s) 4, 6, 5, 14
24 8.6, CH3 1.65 (d, 1.7) 13, 18, 19, 17
Figure 2. Key COSY and HMBC correlations of 1, 2, and 4−6.
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2,3-dihydrofuran (Table 1 and Figures 2 and S13). Key
HMBC correlations from H2-12 to C-13, C-14, and C-17, from
H3-23 to C-14, and from H-15 to C-13 and C-17 documented
the fusion of the 2-hydroxycyclopent-2-en-1-one with the
dihydropyran at C-13/C-14 (Figures 2 and S13). The
deshielded nature of C-16 (δC 153.2) indicated the position
of hydroxylation. HMBC correlations from H3-24 to C-13, C-
17, C-18, and C-19 and from H-19 to C-13 and C-14
established the fusion of the 4-methyl-2,3-dihydrofuran with
the dihydropyran and the 2-hydroxycyclopent-2-en-1-one at C-
13/C-14 to generate a propellane system (Figures 2 and S13).
A NOESY correlation between H-7 and H3-24 suggested a syn-
fusion at C-13/C-14 (Figure S14 and S15). This is the first
report of a dioxa[4.3.3]propellane system consisting of a 5/5/6
fused ring system, and the name neosetophomone A was
ascribed to 1. The absolute configuration of 1 was assigned via
Mosher’s ester method,8 establishing the configuration as
(2S,4S,5S,13S,14S) (Figure 3). The 13C NMR data of 1
compared favorably with those calculated using ACD
laboratories NMR predictor software (Table S2).
Compound 2 (56.38 mg) was obtained as a white
amorphous powder. Its formula was deduced via HRESIMS
as C24H32O4, which was less than that reported for 1 by 16
amu (Figure S3). The NMR data of 2 also indicated structural
similarity to 1 and 3 (Table 2 and Figures S16 and S17). In
comparison with 3, the NMR data indicated that 2 lacked the
dihydropyran/tropolone moiety (i.e., rings A and B), which
was consistent with the molecular weight difference between 2
and 3. Also, when comparing the NMR data of 2 with that of 1,
it was evident that both had an identical humulene moiety
(ring C). However, although the tropolone E in 2 was intact,
that ring underwent oxidative rearrangement in 1 as evidenced
by a 16 amu difference between 1 and 2. As in 1 and 3, the
COSY spectrum of 2 showed three isolated proton spin
systems that were connected via three carbons (C-5, C-9 and
C-1) to constitute the 11-membered sesquiterpene ring, which
was fused with the dihydro-2H-pyran at C-4/C-5 (Figures 2
and S18). HMBC correlations from H-2 to C-11 and C-20,
from H2-3 to C-1 and C-5, from H2-6 to C-8 and C-23, from
H2-10 to C-1, C-8, C-21, C-22, and from H2-12 to C-3, C-5,
and C-19 supported this connectivity (Table 2 and Figures 2
and S19). The olefinic protons of the Δ7,8 double bond were in
the E-configuration (JH‑7/H‑8 = 15.9 Hz) (Table 2 and Figure
S16). The trivial name neosetophomone B was assigned to 2.
A NOSEY correlation was observed between H-11 to H3-20
that confirmed the E-configuration of the Δ1,11 double bond
(Figures S15 and S20). The structure of 2 was confirmed via
single-crystal X-ray diffraction (Figure 4), while its absolute
configuration was assigned via a modified Mosher’s ester
method,8 establishing the configuration as (2S,4S,5S,13S,14S)
(Figure 3). Crystallographic data for compd 2 has been
deposited with the Cambridge Crystallographic Data Centre
(CCDC 1873628).
Compound 4 (6.54 mg) was obtained as a white amorphous
powder. Its formula was deduced via HRESIMS as C33H40O6
(Figure S3). The HRESIMS and NMR data indicated that 4
was a dehydroxy analogue of 3, as evidenced by both a 16 amu
difference in the HRMS data and replacement of the downfield
shifted oxygenated proton in 3 (δH/δC 4.20/70.8, for H-11/C-
11) by two upfield shifted aliphatic protons (δH/δC 1.58/1.95/
Figure 3. ΔδH values [Δδ (in ppm) = δS − δR] obtained for (S)- and
(R)-MTPA esters (A) of neosetophomone A (1) (1a and 1b,
respectively) and (B) of neosetophomone B (2) (2a and 2b,
respectively) in pyridine-d5.
Table 2. 1H (500 MHz) and 13C (100 MHz) NMR data for 2 in CDCl3
position δC, type δH (J, Hz) position δC, type δH (J, Hz)
1 138.0, C 12 34.5, CH2 2.46, dd (17.5, 12.5)
2 67.0, CH 4.76, dd (10.1, 6.1) 2.67, dd (17.5, 5.4)
3 36.7, CH2 1.42, ddd (14.4, 10.1, 1.1) 13 121.5, C
1.89, dt (14.4, 6.1) 14 161.3, C
4 33.0, CH 1.77, m 15 113.7, CH 6.97, s
5 81.4, C 16 163.5, C
6 44.3, CH2 2.32, dd (15.0, 10.0) 17 172.4, C
2.67, ddd (15.0, 2.9, 1.5) 18 124.6, CH 7.10, s
7 119.8, CH 5.07, ddd (15.9, 10.0, 2.9) 19 150.0, C
8 144.7, CH 5.28, dd (15.9, 1.5) 20 18.3, CH3 1.67, s
9 38.6, C 21 21.6, CH3 0.92, s
10 40.6, CH2 1.78, dd (13.0, 7.3) 22 30.2, CH3 1.05, s
2.11, dd (13.0, 9.9) 23 19.5, CH3 1.16, s
11 127.0, CH 5.36, dd (9.9, 7.3) 24 27.2, CH3 2.37, s
Figure 4. X-ray crystallographic structure of 2.
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31.5, for H2-11/C-11) (Tables S1, 3, and 4 and Figure S21).
These data, along with COSY, HSQC, HMBC, and NOESY
data (Figures 2, S15, and S22−S24) confirmed the structure of
4, which was named dehyroxyeupenifeldin.
Compound 5 (10.75 mg) was obtained as a white
amorphous powder. Its formula was deduced via HRESIMS
as C32H40O6, which was less than that reported for 3 by a CO
group (Figure S3,). The NMR data of 5 also indicated
similarity to 3 (Tables S1, 3, and 4 and Figures S25−S27). Key
differences were the splitting and the upfield shift of the
aromatic resonances, for example, δH 6.16 and 6.33, d, J = 1.7
Hz, for H-2 and H-6, respectively, in 5 vs δH 6.90 and 7.13, for
H-3 and H-7, respectively in 3, indicating meta-coupled
aromatic protons in 5. Moreover, the aromatic methyl singlet
H3-27 in 5 was shielded by 0.22 ppm relative to its chemical
shift in 3. In addition, the 13C NMR data of 3 showed two
diagnostic tropolonic carbonyl signals (δC 173.4 and 172.7 for
C-1 and C-25, respectively), while those of 5 showed only one
(δC 172.1 for C-24), which correlated with the 28 amu
difference in HRMS data between these compounds. In total,
these data were consistent with the substitution of the
tropolone B in 3 by a benzene in 5. HMBC correlations
from H2-7 to C-5, C-3, and C-9 supported this substitution
(Figure S28). The skeleton of 5 was confirmed by COSY,
HSQC, and HMBC data (Figures 2 and S26−S28). The
relative configuration of 5 was confirmed to be the same as 3
by NOESY NMR data (Figures S8 and S29). NOESY
correlations from H-8 to H3-28 and H-16, and from H-16 to
H-12, confirmed the syn-fusion at C-8/C-9 and the anti-fusion
at C-12/C-13. The name noreupenifeldin B was ascribed to 5,
which was found to be different from the previously reported
noreupenifeldin.9 Essentially, the position of the tropolone and
the benzene are opposite between these two. An attempt to
assign the absolute configuration of 5 using Mosher’s esters
method8 was unsuccessful, and this finding was consistent with
the challenges reported for determining the absolute
configuration of ramiferin.10
Compound 6 (4.96 mg) was obtained as a light brown
amorphous powder. Its formula was deduced as C31H40O6 by
HRESIMS, which was less than that for 5 by one carbon, as
Table 3. 1H NMR data for 4 (400 MHz, CDCl3), 5 (500
MHz, CDCl3), and 6 (500 MHz, MeOH-d4)
position
4 5 6
δH (J in Hz) δH (J in Hz) δH (J in Hz)
2 6.16 (d, 1.7) 6.14 (d, 2.3)
3 6.92, s
6 6.33 (d, 1.7) 6.23 (d, 2.3)
7 7.13, s 2.28 (dd, 17.2, 15.5) 2.29 (d, 16.0)
2.67 (dd, 17.2, 5.2) 2.72 (dd, 16.0, 4.6)
8 2.32, m 1.73 (ddd, 15.5, 5.2,
4.6)
1.84 (d, 4.6)
2.78, dd (17.2, 5.3)
9 1.83, m
10 4.18 (d, 11.5) 4.22 (d, 11.5)
11 1.58, m 1.53 (dd, 12.6, 11.5) 1.50 (dd, 12.6, 11.5)
1.95, t (11.9) 2.22 (m) 2.29 (m)
12 1.49, m 2.17 (m) 2.19 (m)
2.18, m
13 2.18, m
14 2.50 (dd, 13.2, 10.9) 2.59 (dd, 13.2, 12.6)
2.71 (dd, 13.2, 4.6) 2.79 (dd, 13.2, 3.4)
15 2.53, m 5.63 (ddd, 16.0,
10.9, 4.6)
5.76 (ddd, 16.0,
12.6, 3.4)
2.68, m
16 5.66, ddd (15.9,
11.0, 4.8)
5.80 (d, 16.0) 5.88 (d, 16.0)
17 5.87, d (15.9)
18 0.83 (dd, 14.3, 4.6) 0.76 (dd, 14.9, 5.2)
1.77 (d, 14.3) 1.85 (d, 14.9)
19 0.78, dd (14.4, 4.1) 2.40 (dd, 18.3, 4.0) 2.36 (dd, 16.6, 4.0)
1.67, d (14.4) 3.38 (dd, 18.3, 14.2) 3.25 (d, 16.6)
20 2.35, m
2.67, m
22 6.97 (s)
23 6.94, s
24 6.21 (s)
25 7.15 (s)
26 7.12, s 2.13 (s)
27 2.13 (s) 1.07 (s)
28 2.36, s 1.07 (s) 1.03 (s)
29 1.16, s 1.03 (s) 1.12 (s)
30 1.07, s 1.08 (s) 1.37 (s)
31 1.11, s 1.38 (s) 2.08 (s)
32 1.31, s 2.41 (s)
33 2.41, s
Table 4. 13C NMR Data for 4 (100 MHz, CDCl3), 5 (125
MHz, CDCl3), and 6 (125 MHz, MeOH-d4)
δC, type
position 4 5 6
1 173.4, C 155.2, C 155.8, C
2 162.6, C 101.7, CH 102.7, CH
3 113.2, CH 153.7, C 155.8, C
4 160.8, C 110.9, C 111.5, C
5 118.7, C 139.7, C 140.0, C
6 151.6, C 110.3, CH 111.2, CH
7 125.3, CH 29.8, CH2 30.7, CH2
8 34.0, CH2 32.4, CH 33.8, CH
9 31.6, CH 80.6, C 81.7, C
10 80.0, C 71.1, CH 72.3, CH
11 31.5, CH2 30.4, CH2 32.5, CH2
12 24.5, CH2 41.6, CH 44.1, CH
13 40.9, CH 81.1, C 81.0, C
14 80.2, C 46.5, CH2 47.6, CH2
15 45.4, CH2 125.3, CH 127.1, CH
16 124.5, CH 144.7, CH 145.2, CH
17 144.0, CH 35.1, C 35.8, C
18 35.3, C 46.4, CH2 47.6, CH2
19 47, CH2 33.2, CH2 30.6, CH2
20 31.4, CH2 123.4, C 115.6, C
21 121.0, C 161.0, C 143.0,C
22 160.6, C 114.1, CH 132.6, C
23 113.4, CH 163.3, C 143.8, C
24 163.1, C 172.1, C 109.9, CH
25 172.9, C 124.8, CH 127.3, C
26 124.8, CH 151.1, C 19.7, CH3
27 150.4, C 19.6, CH3 16.1, CH3
28 27.6, CH3 15.8, CH3 30.4, CH3
29 22.8, CH3 29.7, CH3 27.9, CH3
30 29.5, CH3 27.3, CH3 19.6, CH3
31 26.9, CH3 19.4, CH3 18.9, CH3
32 19.6, CH3 27.6, CH3
33 27.4, CH3
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evidenced by a 12 amu difference in the HRMS data (Figure
S3). The NMR data of 6 indicated similarity to 5, except for
the aromatic region (Tables 3 and 4 and Figures S30−S32).
There were several lines of evidence that suggested that 6 did
not contain a tropolone, and these included (a) the lack of a
signal for a carbonyl group, (b) the presence of one singlet
aromatic methine proton (i.e., δH 6.21 for H-24 in 6 vs δH 6.97
and 7.15 for H-22 and H-25, respectively in 5), (c) the
shielding of the aromatic methyl singlet H3-31 in 6 by 0.33
ppm, and (d) a missing carbon resonance. These data
suggested that the tropolone in 5 was replaced by a
pentasubstituted benzene in 6. The 13C NMR data of 6
indicated a 1,2,3-trioxygenated aromatic system (δC 143.0,
132.6, and 143.8 for C-21, C-22, and C-23, respectively)
(Table 4). HMBC correlations from H3-31 to C-20 and C-24,
from H2-19 to C-25, and from H-24 to C-20 and C-23
supported this substitution pattern (Figures 2 and S33). The
skeleton of 6 was further confirmed by COSY, HSQC, and
HMBC data (Figures 2 and S31−33). The relative
configuration of 6 was the same as that of 3 and 5 on the
basis of NOESY NMR data (Figures S15 and S34). For
example, NOESY correlations from H-8 to H3-27 and H-16,
from H-16 to H-14a, and from H-14a to H-12 confirmed the
syn-fusion at C-8/C-9 and the anti-fusion at C-12/C-13. The
name 22-hydroxyramiferin was ascribed to 6, which was found
to be different from the previously described ramiferin, a bis-
phenol analogue of eupenifeldin (3), via a hydroxy at C-22.10
As in 5, we were unable to assign the absolute configuration of
6 using Mosher’s esters method.8
Compounds 1−6 were tested against a panel of cancer cell
lines, including MDA−MB−231 (human breast cancer),
OVCAR-3, and OVCAR-8 (human ovarian cancers), MSTO-
211H (human mesothelioma), LLC (murine lung cancer), and
A549 (human lung cancer) (Table 5). Compound 3 was the
most potent with IC50 values of 2830, 330, 20, 80, 10, and
1330 nM, respectively, followed by compound 4.
While cytotoxicity is essential to the anticancer application
of these compounds, equally important is a lack of toxicity to
healthy tissues. In particular, the clinical failure of numerous
agents due to mitochondrial-based cardio- or hepatotoxicity
has led to an increasing emphasis on mitochondrial toxicity.11
Therefore, compounds 1−3, which represented the greatest
structural diversity among these meroterpenoids, were
evaluated for mitochondrial toxicity in vitro (Promega
Mitochondrial ToxGlo). No toxicity was observed up to the
maximum concentration tested (12.5 μM).
Six meroterpenoids (1−6), of which five are new and one
possesses a novel dioxa[4.3.3]propellane ring system, were
isolated and elucidated from Neosetophoma sp. (strain
MSX50044). Cytotoxicity assays revealed compound 3,
possessing two tropolone moieties, to be the most potent
against a panel of cell lines while not exhibiting toxicity against
mitochondria. Additionally, this fungus is a prolific producer of
3 with a yield that exceeds 28% of the dried organic extract.
Such ample material of a potent, structurally complex
compound opens the door for further studies to enhance
activity and optimize delivery,12 particularly given the in vivo
activity in the P388 leukemia model noted previously.6
Tropolonic sesquiterpenes are a unique subclass of mer-
oterpenoids with a broad range of biological activities,
including cytotoxic,3,6,7,10,13,14 anthelmintic,9 antimalarial,10
and antimicrobial.3 Others have shown a number of tricyclic
propellanes connected by a carbon−carbon single bond that
also display a broad range of activities, including antimicrobial
and anticancer.15,16 These findings highlight the biosynthetic
potential of fungi to create novel chemical structures,
encourage continued discovery of new agents and activities,
and provide motivation to usher natural products to the clinic.
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